Merck & Company Inc - Operating Income

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Operating-Income" stands at 23.39 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

Merck & Company Inc's third quarter result of 7.56 Billion USD for the item "Operating Income" represents an increase of 36.10 percent compared to it's second quarter result.

Also, Merck & Company Inc's third quarter result of 7.56 Billion USD for the item "Operating Income" represents an increase of 89.66 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 23.39 Billion USD for the item "Operating Income" represents an increase of 18.02 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 65.22 percent compared to the value the year prior.
The 1 year change in percent is 65.22.
The 3 year change in percent is 26.15.
The 5 year change in percent is 100.18.
The 10 year change in percent is 228.55.

The Serie's long term average value is 10.16 Billion United States Dollars. It's latest available value, on 09/30/2025, is 130.29 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2023, to it's latest available value, on 09/30/2025, is +692.18%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.